CancerAppy
Novel cancer therapeutic drugs
At CancerAppy, we specialize in cancer research, dedicated to discovering and developing new therapeutic targets. Our proprietary artificial intelligence methodology allows us to accelerate advancements in more effective cancer treatments
Driving innovation in breakthrough oncology treatments.
With our deep expertise in oncology and AI, we analyze vast amounts of multimodal data using advanced AI algorithms. This allows us to identify new therapeutic targets, discover lead compounds, understand their mechanisms of action, and explore potential drug combinations. Our technology also enables the development of next-generation antibody-drug conjugates (ADCs), driving more precise and effective cancer treatments.

We work in the early stage of the Drug Discovery Value Chain.

Our R&D Pipeline
At CancerAppy, we use AI-driven drug discovery to develop new cancer therapies, including novel ADCs (antibody-drug conjugates). Our pipeline moves from target discovery to preclinical development, bringing innovative treatments closer to patients.
News
Latest news about CancerAppy…
Integrating artificial intelligence in drug discovery and early drug development
Cancerappy Participates in New Scientific Publication on AI in Drug Discovery We’re proud to announce that Cancerappy has contributed to a recently...
Cancerappy: Using AI to Advance Cancer Research
Since 2019, Cancerappy has been harnessing the power of artificial intelligence to transform cancer research, from improving detection and diagnosis...
Cancerappy at #Bventure24
We’re back at Bventure! Cancerappy is actively participating in this innovation event through the University of Deusto, joining the roundtable...
Grant CPP2021-008597 funded by:

Grant TQ2020-011486 funded by:


Subvencionado por el CDTI

Somos cliente Enisa

